FOSTER CITY, Calif. (AP) — FOSTER CITY, Calif. (AP) — Gilead Sciences Inc. (GILD) on Tuesday reported third-quarter earnings of $2.18 billion.
On a per-share basis, the Foster City, California-based company said it had net income of $1.73. Earnings, adjusted for one-time gains and costs, were $2.29 per share.
The results exceeded Wall Street expectations. The average estimate of 11 analysts surveyed by Zacks Investment Research was for earnings of $1.91 per share.
The HIV and hepatitis C drugmaker posted revenue of $7.05 billion in the period, which also topped Street forecasts. Nine analysts surveyed by Zacks expected $6.77 billion.
Gilead expects full-year earnings in the range of $6.65 to $6.85 per share, with revenue in the range of $26.7 billion to $26.9 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GILD at https://www.zacks.com/ap/GILD